Deletion of the FOXC2 gene leads to impaired intestinal barrier, and dysregulation of intestinal microbiota and triggers metabolic disorders and systemic inflammation, which in turn exacerbates the onset and progression of T2DM (6). This evidence concerns the gene FOXC2 and metabolic disease.